Document Detail


A classification of retrolental fibroplasia to evaluate vitamin E therapy.
MedLine Citation:
PMID:  583596     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A refined classification of the stages of the retinopathy of prematurity (RLF) based on the experience of over 7500 examinations during the past decade is presented. We have been using the basic elements of this classification since 1972 in order to evaluate the influence of vitamin E on retrolental fibroplasia (RLF). It is our impression that it provides a more accurate clinical method of following the course of the retinopathy and a tool for assessing the factors other than prematurity and hyperoxia that may play a subtle role in the development of RLF.
Authors:
D B Schaffer; L Johnson; G E Quinn; T R Boggs
Related Documents :
15668846 - Cerebrospinal fluid leak in a premature neonate.
19928736 - Importance of the 'third criterion' for retinopathy of prematurity screening in develop...
8714546 - Premature termination of group therapy: a clinical perspective.
7756716 - Use of erythropoietin in premature neonates: controversies and the future.
8659656 - Pregnancy outcomes of us-born and foreign-born japanese americans.
3673756 - Pulse oximetry--an alternative to transcutaneous po2 in sick newborns.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Ophthalmology     Volume:  86     ISSN:  0161-6420     ISO Abbreviation:  Ophthalmology     Publication Date:  1979 Oct 
Date Detail:
Created Date:  1981-02-24     Completed Date:  1981-02-24     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  7802443     Medline TA:  Ophthalmology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1749-60     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Humans
Infant, Newborn
Infant, Premature
Retinal Vessels / pathology
Retinopathy of Prematurity / diagnosis,  drug therapy*,  pathology
Vitamin E / therapeutic use*
Grant Support
ID/Acronym/Agency:
R01 EY 01723/EY/NEI NIH HHS
Chemical
Reg. No./Substance:
1406-18-4/Vitamin E

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fluorescein angiography in retrolental fibroplasia: experience from 1969-1977.
Next Document:  Effects of substituted 1,2,3-triazoles on adenosine deaminase, guanine deaminase and xanthine oxidas...